Mon - Fri 08:00 - 21:00 GMT+3 +44 7788

Sarper Diler

Prof Dr Sarper Diler

(M.D.,PhD, CHTC, D-Hom, IO)

Faculty Member 
Istanbul University Istanbul Medical Faculty, TURKEY
Specialist on Cancer Coaching
 Microbiome-Cancer & Diet, USA
International Hematopoeitic Stemcell Transplantation Coordinator of NMDP, USA
Lymphoma Coalition- Sec Gen, Board of Directors, CANADA
BIRKANKO-Turkish Cancer Coalition- Board of Directors, TURKEY
INSPIRE2LIVE COVID-19 Cancer  Working Group Chair The NETHERLANDS

Founder of Ovital Institute

Certified Doctor in The Gonzalez Protocol®

Chair -The Gonzalez Foundation- Scientific Ad Board



1984 -Tarsus American High School

1991 -İstanbul Medical Faculty, Universite de Paris 7 Hopital Fernand Widal – (M. D.)

1998 -Lund University Faculty of Medicine – (PhD)

2001 -Istanbul University Medical Faculty-  (Assoc. Prof.)

2004-US National Marrow Donor Program-CHTC-Internatioanal CertifiedHematopoietic Transplantation Coordinator

2013- Universite de Paris 7 Hopital Fernand Widal-  (Professor)

2016- University of Colorado Boulder- Microbiome

2019- University of Arizona – Cancer Coaching and Nutrition

2020- The Gonzalez Foundation- Integrative Internal Medicine

2021- Memorial Sloan Kettering Cancer Center – Integrative Oncology





 French, English, Turkish



Positions and Duties


  • International Hematopoietic stemcell transplant coordinator of NMDP, USA( 2004-..)
  • Istanbul Medical Faculty, Bone Marrow Bank- Transplant Coordinator-Executive 1999-2009
  • Universite Paris 7 Integrative Oncology Department- Staff Professor 2018- ..  )
  • European School of Homeopathy Homeopathy Advanced Homeopathy Academic(2020-2021)
  • International Lymphoma Coalition- Board Of Directors (2010-  .. )
  • INSPIRE2LIVE COVID-19 Cancer  Working Group Chair (2019-..)
  • The Gonzalez Foundation Scientific Committee Chair(2021-..)


Scientific Society Memberships



  • European Federation of Immunogenetics -EFI
  • Ordre Medical Conseil Regional Il de France
  • American Society of Histocompatibility and Immunogenetics – ASHI
  • New York Academy of Sciences- NYAS
  • London College of Homeopathy- LCH
  • European Committee of Homeopathy- ECH
  • The Gonzalez Foundation- SAB
  • Bone Marrow Donor Worldwide- BMDW
  • World Marrow Donor Association- WMDA



Recent Prominent Publications of Prof Diler



  1. Arnais -Villena A., Carin M.,Bendikuze N, Gomez-Casado E., Moscosa.J,Oguz FS., Sarper Diler A, De   Pacho A., J.Guillen  J M Laso (2001). HLA alleles and haplotypes in Turkish population: relatedness to Kurds, Armanians and other Mediterraneans. Tissue Antigens 57(4):308-17.
  2. Diler AS, Kekik Ç, Oğuz F, Akar U, Sonmez G, Çarin M (2000). HLA Class I antigens in relation with aplastic anemia and acute leukemias in Turkish population., Tissue antigens, 57(4):30,8- 17
  3. Dorak MT, Oguz FS, Yalman N., Diler AS, Kalayoğlu S, Anak S, Sargın D, Çarin M. (2002). A male specific increase in the HLA-DRB4 (DR53) frequency in high- risk childhood ALL. Leuk. Res 26 (7):651-6 
  4. Oguz FS, Yalman N., Diler AS., Oguz R., Anak S.,Çarin M. (2002). HLA-DRB1*15 and pediatric aplastic anemia Haematologica 87(7):772-4.
  5. Diler AS, Oğuz SF, Erzengin D, Öztürk Ş, Selcuki D, Palandüz S, Camlica, H, Carin M (2002) HLA DRB1 allele polymorphism and sister chromatid exchange frequency in Turkish psoriasis vulgaris patients., Eur J Immonogen, 29, 2-4 (
  6. Oguz FS, Ocal L, Diler AS, Ozkul H, Asicioglu F, Kasapoglu E, Bozkurt G, Konice M, Carin M. (2004). HLA B-27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis Markers;20(6):309-12.
  7. Zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, Kabisch H, Schneppenheim R, Nurnberg P, Janka G, Hennies HC (2005).Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11.
    Hum Mol Genet;14(6):827-34..
  8. Diler AS and Oguz SF(2002). HLA antigens in Psoriasis, Chapter 36pp. 257-307., in Psoriasis and Related disorders-More than Skin Deep ed. Jhercogova, MNL Scientific Publishing, Bologna, Italy
  9. Diler AS, Tozkir H, Senturk-Ciiftci H, Ayna T, OguzSF, Gurtekin M, Aktan M, Carin M (2005). The influence of HLA in Turkish chronic lymphocytic leukemia patients and a familial association. Human Immunology, 66(8), S 1;63 August.
  10. Middleton, D., Meenagh, A., Sleator, C., Gourraud, P. A., Ayna, T., Tozkir, H., Köse, A. A., Azizleri, G., & Diler, AS. (2007). No association of KIR genes with Behcet’s disease. Tissue antigens70(5), 435–438.
  11. Diler, AS., Uzüm, G., Akgün Dar, K., Aksu, U., Atukeren, P., & Ziylan, Y. Z. (2007). Sex differences in modulating blood brain barrier permeability by NO in pentylenetetrazol-induced epileptic seizures. Life sciences80(14), 1274–1281.
  12. Middleton, D., Diler, AS., Meenagh, A., Sleator, C., & Gourraud, P. A. (2009). Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia. Tissue antigens73(6), 553–560.
  13. Shaw, B. E., Ball, L., Beksac, M., Bengtsson, M., Confer, D., Diler, AS., Fechter, M., Greinix, H., Koh, M., Lee, S., Nicoloso-De-Faveri, G., Philippe, J., Pollichieni, S., Pulsipher, M., Schmidt, A., Yang, E., van Walraven, A. M., Clinical Working Group, & Ethics Working Group of the WMDA (2010). Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. Bone marrow transplantation45(5), 832–838.
  14. Lawler, M., Banks, I., Law, K., Albreht, T., Armand, J. P., Barbacid, M., Barzach, M., Bergh, J., Cameron, D., Conte, P., de Braud, F., de Gramont, A., De Lorenzo, F., Diehl, V., Diler, AS., Erdem, S., Geissler, J., Gore-Booth, J., Henning, G., Højgaard, L., … Selby, P. (2017). The European Cancer Patient’s Bill of Rights, update and implementation 2016. ESMO open1(6), e000127.
  15. Kahraman, M., Ozulu Turkmen, B., Bahat-Ozturk, G., Catikkas, N. M., Oren, M. M., Sahin, A., Daglar, A., Ozturk, S., Palanduz, S., Diler, AS., & Karan, M. A. (2021). Is there a relationship between ACTN3 R577X gene polymorphism and sarcopenia?. Aging clinical and experimental research, 10.1007/s40520-021-01996-8. Advance online publication.


Years of Experience

We are no more victims of our genes. At OVITAL, we determine your factory settings and retune ie. personalized balance of the Autonomic Nervous System(ANS) and  harmonize epigenetics including microbiome retuning. We effectively maintain your good health, predict & prevent any disease


Get directions

Find us on map

Contact & Appointment

Make An Appointment

Call : +90 850 441 6656
Fax: +160 6222 3044